GENFLOW BIOSCIENCES PLC (GENF) — research page
UK · uk-cm-kg/LSE/GENF · as of 2026-11-06
Identity and listing
The issuer is GENFLOW BIOSCIENCES PLC, listed on the LSE Main Market under ticker GENF, ISIN GB00BP2C3V08, LEI 213800HVOFXRXVEGDN62. Its security type is Corporate, its segment is SSQ3, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | GENFLOW BIOSCIENCES PLC | source · 2026-11-06 |
| exchange | LSE Main Market | source · 2026-11-06 |
| ticker | GENF | source · 2026-11-06 |
| ISIN | GB00BP2C3V08 | source · 2026-11-06 |
| LEI | 213800HVOFXRXVEGDN62 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | SSQ3 | source · 2026-11-06 |
| sector | Pharmaceuticals and Biotechnology [201030] | source · 2026-11-06 |
| jurisdiction | England and Wales (Companies House jurisdiction field) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 43 filings across 39 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.0 days, against a median of 4 days for the LSE Main Market (892 issuers) and 6.0 days for the sector (51 issuers). Days from the latest filing to the record date are 7, against a median latency of 3 days for the exchange and 4.0 days for the sector. The latest filing is dated 2026-10-30 and is of type corporate_action.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 43 | 7 | 7 |
| exchange median: LSE Main Market (892 issuers) | 29 | 4 | 3 |
| sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers) | 42 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-30 | corporate_action | Total Voting Rights | |
| 2026-10-09 | regulatory_announcement | Corporate Update | |
| 2026-10-07 | ch_capital | capital allotment shares — 2026-10-02 | |
| 2026-10-05 | financial_statement | Presentation of Interim Results | |
| 2026-09-10 | newswire_release | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA - PR Newswire |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows listed, not halted.
Orderability
For the elective professional client category, the signal is ACM-200 and the outcome is determinable. For the eligible counterparty category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.
| client category | outcome |
|---|---|
| elective professional client | ACM-200 |
| eligible counterparty | ACM-200 |
rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read. The count is 0.
Open research
No openly published research notes were found. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- 10.2
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GENF (identity.isin)
- 10.3
- https://find-and-update.company-information.service.gov.uk/company/13138531 (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://www.londonstockexchange.com/stock/GENF/genflow-biosciences-plc/company-page (identity.sector)
- 10.6
- https://mcp.uk-cm-kg.ai/events/LSE/GENF (the disclosure lines)
- 10.7
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- 10.8
- https://genflowbio.com/wp-content/uploads/2023/04/Genflow-Accounts-31-December-2022-v4-FINAL2.pdf (the auditor)
- 10.9
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.10
- https://mcp.uk-cm-kg.ai/record/LSE/GENF (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BP2C3V08"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a7f62d4527932db3.